Diabetes use for Comvita Olive leaf

Comvita's Olive Leaf Extract is effective in improving the way insulin is secreted and works in overweight men, a clinical trial shows.

The Paengaroa-based natural health and beauty products company announced the finding to the New Zealand stock exchange this week.

Comvita Olive leaf complex.

The clinical trial by the Liggins Institute at the University of Auckland found that fresh olive leaf extract prepared by Comvita, improves the way insulin is secreted and works in overweight men. Insulin that does not work effectively can lead to diabetes.

The randomised, double-blinded, placebo-controlled cross-over trial was undertaken by 47 middle-aged and overweight men at risk of developing type-2 diabetes, a disorder characterised by insulin resistance and deficiency. ‘

Trial participants who took olive leaf extract for 12 weeks showed boosted insulin sensitivity and secretion.

The Liggins Institute Director and Principal Investigator Professor Wayne Cutfield and Clinical Research Fellow Dr Martin de Bock have submitted the results for international peer review and publication.

'Due to restrictions around the submission process to the medical journal, further details from the trial can only be discussed after the results have been published,” says Comvita CEO Brett Hewlett.

'However, we expect there will be increased interest in Comvita products as a result of the trial. We're also scoping the possibility of building on this science, with additional clinical trials.

'The study underscores the potential for efficacious, proven natural products to play an integral role in improving health outcomes.”

The research was made possible through collaboration with The Ministry of Business Innovation and Employment's (MBIE) Science + Innovation Group.

0 comments

Leave a Comment


You must be logged in to make a comment.